Clinical Immunology
A section of Vaccines (ISSN 2076-393X).
Section Information
Aims and Scope
Chronic immune mediated inflammatory diseases (IMIDs) comprise a wide spectrum of disorders, which can share risk factors and immonopathogenetic mechanisms and thus benefit from similar therapeutic approaches. Immunopathogenesis of IMIDs may originate and resemble an aberrant immune response to micro-organisms. Therefore, research on IMIDs, defence mechanisms to pathogens and immunity to vaccines may add each other. This section of the Journal welcomes manuscripts on IMIDs from several perspectives, including epidemiology, pathogenesis, animal models, clinical manifestations, disease association, and treatment. Studies on the relationships between IMIDs and infectious disease as well as on side effects of vaccines are also encouraged.
Keywords
- Immune mediated diseases
- Autoimmune diseases
- Allergy
- Chronic inflammatory diseases
- Immune mediated side effects of vaccines
- Epidemiology
- Immunodermatology
- Mucosal Immunity
- Immunopathogenesis
- Animal models
- Clinical manifestations
- Laboratory investigations
- Treatment
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Allergy Immunotherapy and Vaccination (Deadline: 30 September 2023)
- Neuroimmunology - the Past, Present, and Future (Deadline: 30 September 2023)
- Asthma and Allergic Inflammation (Deadline: 17 November 2023)
- The Role of Immune Response in Viruses and Respiratory Allergy (Deadline: 20 November 2023)
- Clinical and Preclinical Development of Bacterial Vaccines (Deadline: 23 November 2023)
- Cutaneous Reactions to Vaccination: Clinical and Histopathological Features (Deadline: 31 December 2023)
- Immunological Aspect regarding Vaccine Development and Uses (Deadline: 31 January 2024)
- Vaccine, Molecular Immunology in the Era of Pandemic and Beyond (Deadline: 31 January 2024)
- Comorbidity and Autoimmune Connective Tissue Disorders: From Bench to Bedside (Deadline: 31 March 2024)
- Measure to Improve Vaccination Coverage In at Risk Categories: Pregnant Women, Healthcare Workers and Patients with Chronic Diseases—Second Edition (Deadline: 31 March 2024)
- Modulation of the Immune System in Inflammatory Diseases and Hidradenitis Suppurativa (Deadline: 31 March 2024)
- Antiviral Approaches, Immunological Interventions and Vaccination for Effective Virus Spread Control and Prevention (Deadline: 30 April 2024)
- Spotlight on the Impact of Coinfections with Tropical Pathogens on COVID-19 Vaccines Efficacy and Clinical Outcomes of SARS-CoV-2 Infections (Deadline: 31 May 2024)
